Syngenta invests in US biomarker firm
Syngenta has made an undisclosed equity investment in the US biochemical profiling company, Metabolon (Research Triangle Park, North Carolina). It is the first investment by Syngenta’s new venture capital subsidiary, Syngenta Ventures. Metabolon specialises in biomarker discovery. The technology can be used to accelerate the development of plants with new native and genetically modified traits, Syngenta says.